Skip to main content
Institutional profile

CMR Surgical

CMR Surgical is one of the most important independent surgical robotics firms and a major challenger in soft-tissue robotic surgery. Its Versius platform is designed to be compact, modular, and adaptable across operating-room environments, with an emphasis on expanding access to robotic-assisted minimally invasive surgery.

  • Highest 2026 tier: Tier II
  • Surgical Robotics & Advanced Equipment Firms
  • 2 ranking categories

Overview

CMR Surgical is one of the most important independent surgical robotics firms and a major challenger in soft-tissue robotic surgery. Its Versius platform is designed to be compact, modular, and adaptable across operating-room environments, with an emphasis on expanding access to robotic-assisted minimally invasive surgery.

CMR’s strength lies in its differentiated system architecture and international adoption. The company’s Versius platform has been used across multiple countries and received U.S. FDA marketing authorization for cholecystectomy, establishing a pathway into the world’s largest surgical robotics market. More recent reports noted that Versius Plus received FDA clearance and that CMR expected commercialization activity in 2026.

CMR Surgical is included in 2 2026 ranking categories. Its highest classification is Tier II. Ranking recognition is category-specific editorial evidence rather than a substitute for independent diligence.

Firm facts

Public identityCMR Surgical
Founded2014
Institution typeSurgical Robotics & Advanced Equipment Firms institution
HeadquartersCambridge, United Kingdom
Primary focusSurgical Robotics & Advanced Equipment Firms
Highest 2026 ranking tierTier II

Principal activities

CMR’s strength lies in its differentiated system architecture and international adoption. The company’s Versius platform has been used across multiple countries and received U.S. FDA marketing authorization for cholecystectomy, establishing a pathway into the world’s largest surgical robotics market. More recent reports noted that Versius Plus received FDA clearance and that CMR expected commercialization activity in 2026.

Core capability

Surgical Robotics & Advanced Equipment Firms

Client relevance

Category-specific capability, institutional credibility and the ability to support demanding professional, commercial or patient needs.

Execution and verification

Current service scope, leadership, geographic coverage, legal entities and regulated activities should be confirmed directly.

Sector and mandate coverage

Primary category

Surgical Robotics & Advanced Equipment Firms

Institutional context

Coverage reflects the institution’s role in the ranking categories listed below. Precise services, products, jurisdictions, clinical scope and client eligibility should be verified for each use case.

Market position

CMR Surgical’s Versius platform, regulatory progress, international adoption, and focused robotic surgery identity support its inclusion among established surgical robotics firms.

CMR Surgical is assessed through public institutional information and Ranking News editorial research. Its strongest 2026 result is Tier II.

Competitive context

The relevant peer set varies by category, geography, client segment and mandate. CMR Surgical should be compared on current category-specific capability, senior involvement, evidence of comparable work, operating resilience and any applicable regulatory or clinical permissions.

Comparable institutions are shown for navigation and market context. Inclusion does not imply identical scale, ownership, geographic coverage, service model or regulatory status.

Leadership and governance

Leadership, ownership, governance and senior-team responsibilities may change. Current information should be verified through authoritative institutional sources.

Corporate and public information

The public-facing organization is identified here as CMR Surgical. Contracting entities, regulated affiliates, clinical operations, offices and legal permissions may differ by service and jurisdiction.

Corporate and disclosure information
OrganizationCMR Surgical
HeadquartersCambridge, United Kingdom
Verification noteConfirm legal entity, licenses, offices and engagement terms directly before appointment or use.

Rankings and recognition

Ranking inclusion and tier classification are editorial determinations. They should be read as category-specific assessments rather than universal league-table positions. The existence or maintenance of this Wiki profile does not influence ranking eligibility, tier or position.

Related Economy analysis

Selected reporting and market analysis from The Economy provides context for the institution’s operating environment:

Sources and data transparency

Official institutional information, where available, is used for current public identity and capabilities. Ranking pages document 2026 category and tier status. Economy articles provide market context rather than institution-specific endorsement.

  1. Healthcare Ranking — Top 30 Surgical Robotics & Advanced Equipment Firms 2026 — 2026 inclusion and tier classification.
  2. Healthcare Ranking — Top 30 Surgical Robotics & Advanced Equipment Firms 2026 — 2026 inclusion and tier classification.
  3. The Economy — Healthcare Rankings and the New Economics of Expertise — market context.
  4. The Economy — Healthcare Market Structure Is Opening a New Lane for Specialist Providers — market context.
  5. The Economy — Healthcare Rankings and the New Geography of Distributed Care — market context.

First published: 29 August 2026

Last substantively reviewed: 29 August 2026

Profile scope: Surgical Robotics & Advanced Equipment Firms

This profile has been compiled from publicly available institutional and editorial sources. The profiled organization does not determine its inclusion, editorial characterization or ranking status. Corrections supported by authoritative documentation may be submitted to The Economy Wiki.